The Novel Lipid-Based Chronic Disease Model in Lifestyle Medicine: Impact on Prevention of Atherosclerotic Cardiovascular Disease

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations

Abstract

The lipid-based chronic disease (LBCD) model is a novel mechanism for clinical use in the management of patients with elevated lipid values. The four stages of LBCD are risk, pre-disease (abnormal lipoprotein synthesis), disease (dyslipidemia), and complications (e.g., atherosclerosis). The main drivers of LBCD are inherent, but lifestyle factors can play a significant role in the progression of LBCD. Certain inherent factors can lead to LBCD stage 3 since birth, and the focus will be to prevent progression to LBCD stage 4 in these patients. Lifestyle interventions can help mitigate the impact of LBCD and should be incorporated into all stages of LBCD. The LBCD model provides a practical guide for early lifestyle intervention and progression of the disease.

Original languageEnglish
Title of host publicationLifestyle Medicine
Subtitle of host publicationClosing Research, Practice, and Knowledge Gaps
PublisherSpringer Science+Business Media
Pages75-102
Number of pages28
ISBN (Electronic)9783031828881
ISBN (Print)9783031828874
DOIs
StatePublished - 1 Jan 2025

Keywords

  • Atherosclerosis
  • Cardiometabolic
  • Chronic disease
  • Dyslipidemia
  • Lifestyle medicine
  • Lipoproteins
  • Prevention

Fingerprint

Dive into the research topics of 'The Novel Lipid-Based Chronic Disease Model in Lifestyle Medicine: Impact on Prevention of Atherosclerotic Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this